Surgical treatment of inferior vena cava tumour thrombi in kidney cancer

The formation of a cancerous blood clot, or thrombus, in one of the main veins that transport blood from the body to the heart, the inferior vena cava, can be a complication in patients with renal cell carcinoma (RCC), occurring in 5-15% of cases. A recent study investigated the surgical treatment of kidney cancer patients […]

read more

Renal artery embolisation before surgery for large complex kidney tumours

Renal artery embolisation is sometimes performed before the surgical removal of large and complex kidney tumours. It can be used to induce the death of the tumour by cutting off the blood supply, and helps the surgical removal of the tumour through reducing bleeding during the operation. Moreover, in metastatic renal cell carcinoma (RCC) it […]

read more

Right-sided kidney tumours have better outcomes

In a recent paper published in Cancer Medicine from researchers in Boston, USA, people with a large (10 cm or larger) renal cell carcinoma (RCC) tumour on their right kidney had a significant 15% decreased risk of death and better cancer-specific survival than left-sided RCC. Read more in Renal & Urology News here

read more

Role of stereotactic ablative radiotherapy for primary renal cell carcinoma

This paper reviews the use of stereotactic ablative radiotherapy (SABR) (also called stereotactic body radiotherapy, SBRT) for treating primary renal cell carcinoma (RCC) that cannot be removed with surgery. SABR is a treatment that automatically targets high doses of radiotherapy to the tumour with high precision. SABR is very accurate, and thereby maximises the cell-killing […]

read more

Potential biomarkers for kidney cancer

Two recent studies have identified potential biomarkers for renal cell carcinoma (RCC). The first study, published in Molecular Medicine Report this month, identified a gene called centrosomal protein 55 (CEP55), which may be considered a potential diagnostic and prognostic biomarker for clear cell RCC when levels are raised in tumour samples. The second study, published […]

read more

Microwave ablation for small kidney tumours

A recent retrospective review of the literature and clinical trials, published in the¬†American Journal of Roentgenology (AJR), reports percutaneous (through the skin) microwave ablation (MWA) is a promising treatment strategy for patients with early stage¬†cT1 kidney tumours. The review suggests that more research into the selection of patients for this treatment, and the risks associated […]

read more

New artificial intelligence technique could help predict how cancer will mutate

New research, published in the journal Nature Methods, describes a new artificial intelligence (AI) technique that could help doctors predict how cancer tumours will mutate, and eventually allow them to personalise each individual’s treatment earlier. The research was conducted at The Institute of Cancer Research (ICR) in London, and has resulted in the development of […]

read more

Rupture of kidney cysts during nephrectomy does not spread cancer

A recent paper, published in Journal of Urology, has shown that there were no local or metastatic recurrences of kidney cancer in a group of patients where there was rupture of a cyst in a malignant tumour during surgery to remove the part of the kidney containing the tumour (partial nephrectomy). The researchers concluded that […]

read more

Outcomes after cryoablation versus nephrectomy

Percutaneous cryoablation (cryotherapy) is emerging as an alternative to partial nephrectomy (PN) for the removal of small, single kidney tumours while conserving kidney function (nephron-sparing). A new study provides support for cryotherapy, finding no significant differences in the risk for complications, kidney function, and cancer control outcomes compared with partial nephrectomy. The investigators suggested that […]

read more
Showing all 9 results
  TOP